News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
345,529 Results
Type
Article (13962)
Company Profile (28)
Press Release (331539)
Multimedia
Podcasts (9)
Webinars (6)
Section
Business (108789)
Career Advice (700)
Deals (20069)
Drug Delivery (39)
Drug Development (47089)
Employer Resources (69)
FDA (8517)
Job Trends (7027)
News (185702)
Policy (16191)
Tag
Academia (1124)
Accelerated approval (2)
Adcomms (17)
Allergies (54)
Alliances (23195)
ALS (36)
Alzheimer's disease (829)
Antibody-drug conjugate (ADC) (64)
Approvals (8578)
Artificial intelligence (147)
Autoimmune disease (11)
Automation (4)
Bankruptcy (175)
Best Places to Work (6157)
BIOSECURE Act (4)
Biosimilars (33)
Biotechnology (25)
Bladder cancer (59)
Brain cancer (17)
Breast cancer (148)
Cancer (1439)
Cardiovascular disease (94)
Career advice (599)
Career pathing (13)
CAR-T (99)
Cell therapy (259)
Cervical cancer (13)
Clinical research (39548)
Collaboration (453)
Compensation (104)
Complete response letters (8)
COVID-19 (1042)
CRISPR (26)
C-suite (141)
Cystic fibrosis (46)
Data (1611)
Decentralized trials (1)
Denatured (4)
Depression (23)
Diabetes (158)
Diagnostics (3385)
Digital health (9)
Diversity (3)
Diversity, equity & inclusion (21)
Drug discovery (60)
Drug pricing (49)
Drug shortages (17)
Duchenne muscular dystrophy (47)
Earnings (55754)
Editorial (16)
Employer branding (9)
Employer resources (59)
Events (49350)
Executive appointments (384)
FDA (9384)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (358)
Gene editing (60)
Generative AI (14)
Gene therapy (179)
GLP-1 (267)
Government (1918)
Grass and pollen (3)
Guidances (94)
Healthcare (9117)
Huntington's disease (5)
IgA nephropathy (18)
Immunology and inflammation (48)
Indications (18)
Infectious disease (1125)
Inflammatory bowel disease (84)
Inflation Reduction Act (5)
Influenza (32)
Intellectual property (65)
Interviews (103)
IPO (10450)
IRA (18)
Job creations (1195)
Job search strategy (531)
Kidney cancer (8)
Labor market (6)
Layoffs (107)
Leadership (8)
Legal (3047)
Liver cancer (49)
Lung cancer (213)
Lymphoma (103)
Machine learning (3)
Management (22)
Manufacturing (150)
MASH (41)
Medical device (7032)
Medtech (7033)
Mergers & acquisitions (10030)
Metabolic disorders (354)
Multiple sclerosis (48)
NASH (8)
Neurodegenerative disease (38)
Neuropsychiatric disorders (6)
Neuroscience (1109)
NextGen: Class of 2025 (2646)
Non-profit (1733)
Now hiring (2)
Obesity (171)
Opinion (105)
Ovarian cancer (58)
Pain (52)
Pancreatic cancer (57)
Parkinson's disease (98)
Partnered (5)
Patents (154)
Patient recruitment (84)
Peanut (28)
People (27743)
Pharmaceutical (16)
Pharmacy benefit managers (7)
Phase I (12151)
Phase II (17271)
Phase III (13357)
Pipeline (946)
Policy (39)
Postmarket research (1284)
Preclinical (4789)
Press Release (19)
Prostate cancer (61)
Psychedelics (12)
Radiopharmaceuticals (155)
Rare diseases (193)
Real estate (2146)
Recruiting (25)
Regulatory (12394)
Reports (15)
Research institute (1036)
Resumes & cover letters (95)
Rett syndrome (4)
RNA editing (2)
RSV (23)
Schizophrenia (38)
Series A (60)
Series B (47)
Service/supplier (3)
Sickle cell disease (28)
Special edition (2)
Spinal muscular atrophy (52)
Sponsored (17)
Startups (1253)
Stomach cancer (7)
Supply chain (33)
Tariffs (8)
The Weekly (4)
Vaccines (270)
Venture capitalists (9)
Weight loss (92)
Women's health (11)
Worklife (9)
Date
Today (187)
Last 7 days (537)
Last 30 days (1733)
Last 365 days (19507)
2025 (6602)
2024 (21124)
2023 (24319)
2022 (29776)
2021 (31984)
2020 (30289)
2019 (22980)
2018 (17385)
2017 (17952)
2016 (15795)
2015 (19403)
2014 (13570)
2013 (10453)
2012 (11172)
2011 (11998)
2010 (10741)
Location
Africa (370)
Alabama (18)
Alaska (2)
Arizona (76)
Arkansas (4)
Asia (25151)
Australia (5664)
California (3626)
Canada (1379)
China (362)
Colorado (157)
Connecticut (178)
Delaware (85)
Europe (48938)
Florida (563)
Georgia (94)
Idaho (27)
Illinois (282)
India (23)
Indiana (171)
Iowa (1)
Japan (127)
Kansas (32)
Kentucky (8)
Louisiana (7)
Maine (49)
Maryland (483)
Massachusetts (2602)
Michigan (95)
Minnesota (178)
Missouri (45)
Montana (19)
Nebraska (9)
Nevada (47)
New Hampshire (43)
New Jersey (1194)
New Mexico (8)
New York (1140)
North Carolina (550)
North Dakota (4)
Northern California (1575)
Ohio (103)
Oklahoma (4)
Oregon (9)
Pennsylvania (838)
Puerto Rico (10)
Rhode Island (9)
South America (596)
South Carolina (15)
Southern California (1427)
Tennessee (52)
Texas (552)
United States (13612)
Utah (98)
Virginia (89)
Washington D.C. (27)
Washington State (392)
West Virginia (2)
Wisconsin (23)
345,529 Results for "mundipharma international limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc. Enter Agreement to Transfer License of FOLOTYN® (Pralatrexate) in China to CASI Pharmaceuticals
CASI Pharmaceuticals, Inc. announced the execution of an Assignment Agreement with Mundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc. for the commercialization of FOLOTYN® in the People’s Republic of China.
August 1, 2023
·
7 min read
Biotech Beach
Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline
Cidara Therapeutics, Inc. announced that it has entered into an asset purchase agreement with its current partner, Mundipharma*, for the divestiture of rezafungin.
April 24, 2024
·
4 min read
Qilian International Holding Group Limited Announces 1 for 5 Reverse Share Split
Qilian International Holding Group Limited, a China-based pharmaceutical and chemical products manufacturer, announced that an 1 for 5 reverse split of its authorized share capital, was approved by the Company’s board of directors on May 29, 2023 and will become effective on June 21, 2024.
June 18, 2024
·
4 min read
Press Releases
Health Canada approves IMFINZI® (durvalumab) as the first and only immunotherapy regimen for adult patients with limited-stage small cell lung cancer (LS-SCLC)
April 10, 2025
·
6 min read
Press Releases
UTime Limited to Participate in International Medical Fairs and Medical Conferences
August 23, 2024
·
3 min read
Press Releases
Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering
May 6, 2025
·
4 min read
Biotech Bay
Cutera Announces the International Limited Commercial Release of AviClear® at IMCAS World Congress 2024
CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced the international limited commercial release of AviClear, the first energy-based device FDA-cleared for the long-term treatment of mild, moderate, and severe acne.
February 8, 2024
·
4 min read
Press Releases
Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering
April 14, 2025
·
5 min read
Biotech Beach
Cidara Therapeutics Receives $11.1 Million Milestone Payment from Mundipharma
Cidara Therapeutics, Inc. announced receipt of an $11 million milestone payment from Mundipharma under the licensing agreement established between the two companies in September 2019.
October 4, 2022
·
4 min read
Press Releases
Dynavax Adopts Limited-Duration Stockholder Rights Plan
October 30, 2024
·
5 min read
1 of 34,553
Next
